Summary
This 2023 narrative review in Heart Failure Reviews synthesises contemporary clinical knowledge on ischaemic cardiomyopathy across epidemiological, pathophysiological and therapeutic dimensions. The authors examine disease burden, underlying mechanisms and evidence-based management strategies to inform clinical practice. The work represents a clinical synthesis rather than primary research, positioning contemporary therapeutic approaches within the broader context of this major aetiology of heart failure.
Regional applicability
As a clinical review of ischaemic cardiomyopathy management, the findings are broadly applicable to UK cardiology practice and NHS commissioning of heart failure services, though specific epidemiological data would reflect the study population rather than UK prevalence.
Key measures
Disease burden, prevalence, incidence, pathophysiological mechanisms, mortality, morbidity, and efficacy of pharmacological and device-based interventions
Outcomes reported
The review synthesises current clinical knowledge on ischaemic cardiomyopathy across epidemiological patterns, underlying pathophysiological mechanisms, disease outcomes and evidence-based therapeutic options.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.